Table 2.
IL-10 and IL-12 in patients with different pathologies of the studied group.
| IL-10 | P value | IL-12 | P value | |
|---|---|---|---|---|
| Chronic liver Disease |
||||
| HCC (n = 15) | 16.13 ± 1.1 | <0.0001 | 656.9 ± 19.11 | <0.0001 |
| LC (n = 16) | 14.3 ± 0.765 | 505.8 ± 20.8 | ||
| PCH (n = 10) | 6.47 ± 0.596 | 487.7 ± 17.2 | ||
| NDC (n = 10) | 6.04 ± 0.568 | 258.4 ± 14.06 | ||
| HCC grading | ||||
| Grade I (n = 2) | 16.6 ± 0.565 | 0.87 | 656.5 ± 34.648 | 0.9 |
| Grade II (n = 4) | 16.3 ± 0.72 | 659.75 ± 22.98 | ||
| Grade III (n = 9) | 15.9 ± 1.33 | 655.7 ± 16.9 | ||
| Child score | ||||
| A (n = 3) | 16.13 ± 0.305 | 0.7 | 664.3 ± 16.04 | 0.59 |
| B (n = 6) | 15.98 ± 1.15 | 658.3 ± 23.6 | ||
| C (n = 6) | 16.28 ± 1.4 | 651.8 ± 19.1 |
Data expressed as mean ± SD.
P value <0.05 is considered significant.